Intravesical Gemcitabine Therapy Cuts Bladder Cancer Recurrence

TUESDAY, May 8, 2018 -- Immediate post-resection intravesical installation of gemcitabine is associated with reduced recurrence over four years for patients with suspected low-grade non-muscle-invasive urothelial cancer, according to a study...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news